Navigation Links
Isis Reports Financial Results and Highlights for 2012
Date:2/28/2013

opportunities for significant near-term revenue from partnerships while we are also setting the stage for significant future revenue growth," said Elizabeth L. Hougen, chief financial officer of Isis. 

"In 2013, we are predicting another year of strong financial performance while continuing to advance our pipeline. Although we are planning to have more than a dozen drugs in later-stage clinical studies throughout the year, we are projecting only a slight increase in our 2013 spending compared to 2012. As such, we expect to end 2013 with a pro forma NOL in the mid $60 million range. We are also projecting to end the year with more than $325 million in cash. Our guidance is supported by our partnering successes in 2012. Because most drugs are not profitable in their first year of commercialization, and because it is too early in the year to predict the revenue trajectory of KYNAMRO, we are being conservative in our projections by not including KYNAMRO profit share revenue this year.  We are pleased with the significant investment Genzyme is making to ensure a successful KYNAMRO launch.  This investment should support strong revenue growth in the future.  We are fortunate to have Genzyme with its expertise in selling and marketing orphan drugs commercializing KYNAMRO and we look forward to providing updates throughout the year on KYNAMRO's commercial success," concluded Ms. Hougen.

Upcoming Key Milestones

  • Receive KYNAMRO marketing opinion from the European regulatory agency
  • Initiate a Phase 2/3 program of ISIS-SMNRx in infants with spinal muscular atrophy
  • Report clinical data on ISIS-SMNRx at the American Academy of Neurology meeting in March
  • Report clinical data on ISIS-CRPRx in patients with rheumatoid arthritis
  • Report clinical data on ISIS-APOCIIIRx in patients with high triglycerides
  • Financial Results
    All pro forma amounts refer
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
    2. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
    3. Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
    4. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
    5. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
    6. Kewaunee Scientific Reports Improved Results for Third Quarter
    7. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
    8. Questcor Reports Fourth Quarter and Full Year 2012 Results
    9. ResearchMoz: Global MRI Systems Market to 2018 - Technological Advancements, Increasing Number of Applications and Advent of MRI Compatible Pacemakers to Drive Future Growth - Market Research Reports
    10. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
    11. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2015)... -- Bronstein, Gewirtz & Grossman, LLC is investigating potential ... Celladon Corporation ("Celladon" or the "Company") (NasdaqGM: CLDN -News).  ... or his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Celladon and certain of its ... of the Securities Exchange Act of 1934.  ...
    (Date:4/27/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report first quarter ... on Monday, May 11, 2015, followed by ... 4:30pm Eastern.Conference Call & Webcast: Monday, May ... , 888-556-4997International: , 719-457-2628Conference ID: , ...
    (Date:4/27/2015)... Pa. , April 27, 2015  Novira Therapeutics, ... therapies for curative treatment of chronic hepatitis B virus ... data for its lead HBV core inhibitor candidate, NVR ... Association for the Study of the Liver (EASL) in ... antiviral activity of NVR 3-778 from studies performed in ...
    Breaking Medicine Technology:SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3
    ... SAN DIEGO, May 3, 2012  Gen-Probe Incorporated (NASDAQ: ... the following three upcoming investor conferences previously announced on April ... of these investor conferences: , Deutsche Bank 37th ... 1:30 p.m. Eastern Time;  , Baird,s 2012 Growth Stock ...
    ... International, Inc. (Pii), a contract development and manufacturing organization ... announced today that it has made a grant to ... utilized to support pharmaceutical education for graduate students, as ... hot melt extrusion and other pharmaceutical processing technologies. ...
    Cached Medicine Technology:Gen-Probe Withdraws from Previously Announced Investor Presentations 2Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research 2Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research 3
    (Date:4/27/2015)... Jackson, Tennessee (PRWEB) April 27, 2015 A ... to help young people trapped in substance abuse. Programming for ... which will serve girls, is launching this summer. , The ... more than $100,000 to serve adolescents. The Youth Town Jim ... in Collierville on Monday, May 4, with tee times at ...
    (Date:4/27/2015)... MD (PRWEB) April 27, 2015 Jesse ... the 2015–2020 United States Pharmacopeial Convention (USP) at the ... is Professor of Medicine at Georgetown University and the ... and Stewardship (COMPASS). , As USP President, a volunteer ... Convention Meeting. He will be a voting member, ex ...
    (Date:4/27/2015)... UC Davis investigators have settled a ... inherited disorder that historically affected Ashkenazi Jews from ... populations of Semitic descent, particularly families from Saudi ... the researchers uncovered the biochemical underpinnings of Canavan ... incurable and progressively fatal neurological condition. The UC ...
    (Date:4/27/2015)... Based in the Twin Cities of Minneapolis and ... insurance marketing organizations in the country focused on delivering ... as well as employer sponsored ancillary benefits. Spending two ... opportunity to consult with disability insurance carriers, helping to ... , An example of these programs include the most ...
    (Date:4/27/2015)... (PRWEB) April 27, 2015 On April 16, ... Get Rid of Stretch Marks ,” interviewed a UK ... . Stretch marks are a type of scar ... are caused by a breakdown of the elsastin and collagen ... (see: goo.gl/iRdmEe) , “Stretch mark removal with the Coolbeam ...
    Breaking Medicine News(10 mins):Health News:Golf, Sermon on the Mount and More to Support Youth Town’s Jericho and Eden Programs 2Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2
    ... Inc.,(Nasdaq: NXTM ), a leading manufacturer of innovative ... its common stock and,warrants. The private placement consists of ... of $4.50 per share and warrants to purchase 1.9,million ... $5.50 per share,which price may be adjusted to $3.00 ...
    ... /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) (OTC Bulletin Board: ... healthcare related disinfectants in China,announced today that ... of China,s,earthquake relief efforts. The Chinese government, ... on an,unprecedented scale in response to the ...
    ... May 23 Kellogg Company today,announced a $250,000 donation ... efforts in the Sichuan province in southwestern China.,The contribution ... be designated to support the efforts of the Red ... work ahead as people mobilize to rebuild their lives,and ...
    ... Center (MUMC) now offers a type of gallbladder ... belly button. It,s called single,incision laparoscopic surgery, or ... the SILS technique. One of them is Christopher ... the gallbladder through a,1cm. incision in the belly ...
    ... from the Peninsula Medical School in Cornwall, UK, have ... topically applied cream with visible light to destroy cancer ... is applied directly to skin cancers and pre-cancers, which ... red light is then shone on the tumour a ...
    ... Honor, books and DVDs to local schools, SAN ... Medal of Honor Foundation donated 5,000 copies of the,best-selling ... Call of,Duty," to California schools., The book chronicles ... nearly 20 from California, who hold our nation,s,highest award ...
    Cached Medicine News:Health News:NxStage Announces $43 Million Private Placement of Equity Securities 2Health News:NxStage Announces $43 Million Private Placement of Equity Securities 3Health News:NxStage Announces $43 Million Private Placement of Equity Securities 4Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 3Health News:SILS Surgical Technique Now Available at MUMC 2Health News:Let there be light 2Health News:Let there be light 3Health News:TriWest Teaches California Kids About Veteran's Sacrifice, Courage 2
    Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
    Our 'flex' removes the apron weight from the shoulders while providing back support. Unlike other elastic backs, ours does not wrinkle up, making cleaning easier....
    Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
    This battery-powered, single-use pulsed stimulator delivers approximately 0.7mA at 80 pulses per second and uses a subdermal needle as the grounding (anode) electrode. A "current flow" confirmation l...
    Medicine Products: